nodes	percent_of_prediction	percent_of_DWPC	metapath
Flutamide—AHR—breast cancer	0.159	0.387	CbGaD
Flutamide—CYP1B1—breast cancer	0.0916	0.222	CbGaD
Flutamide—AR—breast cancer	0.0803	0.195	CbGaD
Flutamide—AR—Fluoxymesterone—breast cancer	0.0789	0.211	CbGbCtD
Flutamide—CYP1A1—breast cancer	0.0494	0.12	CbGaD
Flutamide—CYP3A4—breast cancer	0.0316	0.0766	CbGaD
Flutamide—CYP1A1—Toremifene—breast cancer	0.0299	0.0799	CbGbCtD
Flutamide—CYP1B1—Tamoxifen—breast cancer	0.0249	0.0665	CbGbCtD
Flutamide—CYP1B1—Mitoxantrone—breast cancer	0.0243	0.0648	CbGbCtD
Flutamide—CYP1B1—Paclitaxel—breast cancer	0.0194	0.0517	CbGbCtD
Flutamide—CYP1A2—Anastrozole—breast cancer	0.0146	0.039	CbGbCtD
Flutamide—CYP1B1—Docetaxel—breast cancer	0.014	0.0374	CbGbCtD
Flutamide—CYP1A2—Toremifene—breast cancer	0.0134	0.0357	CbGbCtD
Flutamide—CYP3A5—Lapatinib—breast cancer	0.0131	0.035	CbGbCtD
Flutamide—CYP1A1—Tamoxifen—breast cancer	0.0109	0.0292	CbGbCtD
Flutamide—CYP2C19—Lapatinib—breast cancer	0.0106	0.0282	CbGbCtD
Flutamide—CYP1B1—Doxorubicin—breast cancer	0.0105	0.0279	CbGbCtD
Flutamide—CYP3A4—Exemestane—breast cancer	0.0101	0.027	CbGbCtD
Flutamide—CYP3A4—Letrozole—breast cancer	0.00859	0.0229	CbGbCtD
Flutamide—CYP3A4—Anastrozole—breast cancer	0.00766	0.0204	CbGbCtD
Flutamide—CYP3A4—Toremifene—breast cancer	0.007	0.0187	CbGbCtD
Flutamide—CYP3A5—Tamoxifen—breast cancer	0.00656	0.0175	CbGbCtD
Flutamide—CYP3A4—Fulvestrant—breast cancer	0.00651	0.0174	CbGbCtD
Flutamide—CYP3A4—Thiotepa—breast cancer	0.0058	0.0155	CbGbCtD
Flutamide—CYP3A4—Ixabepilone—breast cancer	0.00531	0.0142	CbGbCtD
Flutamide—CYP2C19—Tamoxifen—breast cancer	0.00529	0.0141	CbGbCtD
Flutamide—CYP3A4—Lapatinib—breast cancer	0.00511	0.0136	CbGbCtD
Flutamide—CYP3A5—Paclitaxel—breast cancer	0.00511	0.0136	CbGbCtD
Flutamide—CYP3A5—Irinotecan—breast cancer	0.00504	0.0134	CbGbCtD
Flutamide—CYP1A2—Tamoxifen—breast cancer	0.00488	0.013	CbGbCtD
Flutamide—CYP3A4—Raloxifene—breast cancer	0.00387	0.0103	CbGbCtD
Flutamide—CYP3A5—Docetaxel—breast cancer	0.00369	0.00985	CbGbCtD
Flutamide—CYP1A2—Fluorouracil—breast cancer	0.0036	0.0096	CbGbCtD
Flutamide—CYP3A4—Vinorelbine—breast cancer	0.00283	0.00756	CbGbCtD
Flutamide—CYP3A4—Tamoxifen—breast cancer	0.00256	0.00683	CbGbCtD
Flutamide—CYP3A4—Mitoxantrone—breast cancer	0.0025	0.00666	CbGbCtD
Flutamide—CYP3A4—Paclitaxel—breast cancer	0.00199	0.00531	CbGbCtD
Flutamide—CYP3A4—Irinotecan—breast cancer	0.00196	0.00524	CbGbCtD
Flutamide—CYP3A4—Vinblastine—breast cancer	0.00175	0.00466	CbGbCtD
Flutamide—CYP3A4—Docetaxel—breast cancer	0.00144	0.00384	CbGbCtD
Flutamide—AHR—nipple—breast cancer	0.00119	0.0645	CbGeAlD
Flutamide—CYP3A4—Doxorubicin—breast cancer	0.00107	0.00286	CbGbCtD
Flutamide—Nilutamide—AR—breast cancer	0.000907	1	CrCbGaD
Flutamide—CYP1B1—mammary gland—breast cancer	0.000748	0.0406	CbGeAlD
Flutamide—AHR—endometrium—breast cancer	0.000717	0.0389	CbGeAlD
Flutamide—AHR—uterus—breast cancer	0.000661	0.0359	CbGeAlD
Flutamide—AHR—pituitary gland—breast cancer	0.000649	0.0352	CbGeAlD
Flutamide—AHR—adipose tissue—breast cancer	0.000646	0.0351	CbGeAlD
Flutamide—AHR—female reproductive system—breast cancer	0.000594	0.0323	CbGeAlD
Flutamide—AR—nipple—breast cancer	0.000586	0.0318	CbGeAlD
Flutamide—AHR—adrenal gland—breast cancer	0.00058	0.0315	CbGeAlD
Flutamide—AHR—bone marrow—breast cancer	0.000561	0.0305	CbGeAlD
Flutamide—AHR—female gonad—breast cancer	0.00054	0.0294	CbGeAlD
Flutamide—AHR—endocrine gland—breast cancer	0.000503	0.0273	CbGeAlD
Flutamide—CYP1A2—nipple—breast cancer	0.000443	0.0241	CbGeAlD
Flutamide—CYP1A1—nipple—breast cancer	0.000437	0.0238	CbGeAlD
Flutamide—CYP1B1—skin of body—breast cancer	0.000396	0.0215	CbGeAlD
Flutamide—AR—epithelium—breast cancer	0.000394	0.0214	CbGeAlD
Flutamide—AR—skin of body—breast cancer	0.000375	0.0204	CbGeAlD
Flutamide—AR—endometrium—breast cancer	0.000354	0.0192	CbGeAlD
Flutamide—AHR—lymph node—breast cancer	0.000347	0.0189	CbGeAlD
Flutamide—CYP1B1—uterus—breast cancer	0.000344	0.0187	CbGeAlD
Flutamide—CYP1B1—pituitary gland—breast cancer	0.000338	0.0184	CbGeAlD
Flutamide—CYP1B1—adipose tissue—breast cancer	0.000337	0.0183	CbGeAlD
Flutamide—AR—uterus—breast cancer	0.000326	0.0177	CbGeAlD
Flutamide—AR—pituitary gland—breast cancer	0.00032	0.0174	CbGeAlD
Flutamide—AR—adipose tissue—breast cancer	0.000319	0.0173	CbGeAlD
Flutamide—CYP1B1—female reproductive system—breast cancer	0.000309	0.0168	CbGeAlD
Flutamide—CYP1B1—adrenal gland—breast cancer	0.000302	0.0164	CbGeAlD
Flutamide—CYP1A1—epithelium—breast cancer	0.000294	0.016	CbGeAlD
Flutamide—AR—female reproductive system—breast cancer	0.000293	0.0159	CbGeAlD
Flutamide—AR—adrenal gland—breast cancer	0.000286	0.0155	CbGeAlD
Flutamide—CYP1B1—female gonad—breast cancer	0.000281	0.0153	CbGeAlD
Flutamide—CYP1A1—skin of body—breast cancer	0.00028	0.0152	CbGeAlD
Flutamide—AR—female gonad—breast cancer	0.000267	0.0145	CbGeAlD
Flutamide—CYP1B1—endocrine gland—breast cancer	0.000262	0.0142	CbGeAlD
Flutamide—AR—endocrine gland—breast cancer	0.000248	0.0135	CbGeAlD
Flutamide—CYP1A1—uterus—breast cancer	0.000243	0.0132	CbGeAlD
Flutamide—CYP1A1—adipose tissue—breast cancer	0.000238	0.0129	CbGeAlD
Flutamide—CYP3A5—adipose tissue—breast cancer	0.000233	0.0126	CbGeAlD
Flutamide—CYP2C19—endocrine gland—breast cancer	0.00023	0.0125	CbGeAlD
Flutamide—CYP1A1—female reproductive system—breast cancer	0.000219	0.0119	CbGeAlD
Flutamide—CYP1A1—female gonad—breast cancer	0.000199	0.0108	CbGeAlD
Flutamide—CYP3A5—female gonad—breast cancer	0.000195	0.0106	CbGeAlD
Flutamide—CYP1A2—endocrine gland—breast cancer	0.000188	0.0102	CbGeAlD
Flutamide—CYP1A1—endocrine gland—breast cancer	0.000185	0.0101	CbGeAlD
Flutamide—CYP1B1—lymph node—breast cancer	0.000181	0.00983	CbGeAlD
Flutamide—CYP3A5—endocrine gland—breast cancer	0.000181	0.00983	CbGeAlD
Flutamide—AR—lymph node—breast cancer	0.000171	0.00931	CbGeAlD
Flutamide—CYP3A4—female reproductive system—breast cancer	0.00016	0.00872	CbGeAlD
Flutamide—CYP3A4—endocrine gland—breast cancer	0.000136	0.00738	CbGeAlD
Flutamide—CYP1A1—lymph node—breast cancer	0.000128	0.00695	CbGeAlD
Flutamide—Constipation—Mitoxantrone—breast cancer	4.93e-05	0.000439	CcSEcCtD
Flutamide—Constipation—Irinotecan—breast cancer	4.93e-05	0.000439	CcSEcCtD
Flutamide—Toxic epidermal necrolysis—Epirubicin—breast cancer	4.92e-05	0.000438	CcSEcCtD
Flutamide—Aspartate aminotransferase increased—Epirubicin—breast cancer	4.92e-05	0.000438	CcSEcCtD
Flutamide—Rash—Goserelin—breast cancer	4.92e-05	0.000438	CcSEcCtD
Flutamide—Dermatitis—Goserelin—breast cancer	4.91e-05	0.000437	CcSEcCtD
Flutamide—Somnolence—Fluorouracil—breast cancer	4.9e-05	0.000437	CcSEcCtD
Flutamide—Headache—Goserelin—breast cancer	4.89e-05	0.000435	CcSEcCtD
Flutamide—Anxiety—Paclitaxel—breast cancer	4.88e-05	0.000435	CcSEcCtD
Flutamide—Erythema—Docetaxel—breast cancer	4.88e-05	0.000435	CcSEcCtD
Flutamide—Decreased appetite—Gemcitabine—breast cancer	4.88e-05	0.000434	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—breast cancer	4.87e-05	0.000433	CcSEcCtD
Flutamide—Nausea—Tamoxifen—breast cancer	4.85e-05	0.000432	CcSEcCtD
Flutamide—Discomfort—Paclitaxel—breast cancer	4.84e-05	0.000431	CcSEcCtD
Flutamide—Fatigue—Gemcitabine—breast cancer	4.84e-05	0.000431	CcSEcCtD
Flutamide—Constipation—Gemcitabine—breast cancer	4.8e-05	0.000427	CcSEcCtD
Flutamide—Decreased appetite—Fluorouracil—breast cancer	4.8e-05	0.000427	CcSEcCtD
Flutamide—Asthenia—Thiotepa—breast cancer	4.79e-05	0.000426	CcSEcCtD
Flutamide—Diarrhoea—Vinorelbine—breast cancer	4.78e-05	0.000426	CcSEcCtD
Flutamide—Nausea—Melphalan—breast cancer	4.75e-05	0.000423	CcSEcCtD
Flutamide—Feeling abnormal—Mitoxantrone—breast cancer	4.75e-05	0.000423	CcSEcCtD
Flutamide—Feeling abnormal—Irinotecan—breast cancer	4.75e-05	0.000423	CcSEcCtD
Flutamide—Confusional state—Paclitaxel—breast cancer	4.74e-05	0.000422	CcSEcCtD
Flutamide—Erythema—Capecitabine—breast cancer	4.72e-05	0.000421	CcSEcCtD
Flutamide—Pruritus—Thiotepa—breast cancer	4.72e-05	0.00042	CcSEcCtD
Flutamide—Oedema—Paclitaxel—breast cancer	4.7e-05	0.000418	CcSEcCtD
Flutamide—Erectile dysfunction—Methotrexate—breast cancer	4.65e-05	0.000414	CcSEcCtD
Flutamide—Nausea—Goserelin—breast cancer	4.63e-05	0.000413	CcSEcCtD
Flutamide—Feeling abnormal—Gemcitabine—breast cancer	4.62e-05	0.000412	CcSEcCtD
Flutamide—Dizziness—Vinorelbine—breast cancer	4.62e-05	0.000411	CcSEcCtD
Flutamide—Photosensitivity reaction—Methotrexate—breast cancer	4.61e-05	0.00041	CcSEcCtD
Flutamide—Thrombocytopenia—Paclitaxel—breast cancer	4.6e-05	0.00041	CcSEcCtD
Flutamide—Diarrhoea—Thiotepa—breast cancer	4.56e-05	0.000406	CcSEcCtD
Flutamide—Skin disorder—Paclitaxel—breast cancer	4.56e-05	0.000406	CcSEcCtD
Flutamide—Toxic epidermal necrolysis—Doxorubicin—breast cancer	4.55e-05	0.000405	CcSEcCtD
Flutamide—Aspartate aminotransferase increased—Doxorubicin—breast cancer	4.55e-05	0.000405	CcSEcCtD
Flutamide—Feeling abnormal—Fluorouracil—breast cancer	4.55e-05	0.000405	CcSEcCtD
Flutamide—Anaemia—Docetaxel—breast cancer	4.51e-05	0.000402	CcSEcCtD
Flutamide—Drowsiness—Methotrexate—breast cancer	4.5e-05	0.000401	CcSEcCtD
Flutamide—Anorexia—Paclitaxel—breast cancer	4.48e-05	0.000399	CcSEcCtD
Flutamide—Vomiting—Vinorelbine—breast cancer	4.44e-05	0.000395	CcSEcCtD
Flutamide—Dizziness—Thiotepa—breast cancer	4.41e-05	0.000393	CcSEcCtD
Flutamide—Rash—Vinorelbine—breast cancer	4.4e-05	0.000392	CcSEcCtD
Flutamide—Dermatitis—Vinorelbine—breast cancer	4.4e-05	0.000392	CcSEcCtD
Flutamide—Ill-defined disorder—Capecitabine—breast cancer	4.38e-05	0.00039	CcSEcCtD
Flutamide—Headache—Vinorelbine—breast cancer	4.38e-05	0.00039	CcSEcCtD
Flutamide—Leukopenia—Docetaxel—breast cancer	4.37e-05	0.000389	CcSEcCtD
Flutamide—Anaemia—Capecitabine—breast cancer	4.37e-05	0.000389	CcSEcCtD
Flutamide—Photosensitivity reaction—Epirubicin—breast cancer	4.31e-05	0.000384	CcSEcCtD
Flutamide—Haematuria—Methotrexate—breast cancer	4.29e-05	0.000382	CcSEcCtD
Flutamide—Hyperglycaemia—Epirubicin—breast cancer	4.26e-05	0.000379	CcSEcCtD
Flutamide—Malaise—Capecitabine—breast cancer	4.26e-05	0.000379	CcSEcCtD
Flutamide—Insomnia—Paclitaxel—breast cancer	4.25e-05	0.000378	CcSEcCtD
Flutamide—Vomiting—Thiotepa—breast cancer	4.24e-05	0.000378	CcSEcCtD
Flutamide—Leukopenia—Capecitabine—breast cancer	4.23e-05	0.000377	CcSEcCtD
Flutamide—Hypertension—Docetaxel—breast cancer	4.21e-05	0.000375	CcSEcCtD
Flutamide—Drowsiness—Epirubicin—breast cancer	4.21e-05	0.000375	CcSEcCtD
Flutamide—Rash—Thiotepa—breast cancer	4.21e-05	0.000375	CcSEcCtD
Flutamide—Dermatitis—Thiotepa—breast cancer	4.2e-05	0.000374	CcSEcCtD
Flutamide—Headache—Thiotepa—breast cancer	4.18e-05	0.000372	CcSEcCtD
Flutamide—Somnolence—Paclitaxel—breast cancer	4.18e-05	0.000372	CcSEcCtD
Flutamide—Nausea—Vinorelbine—breast cancer	4.15e-05	0.000369	CcSEcCtD
Flutamide—Asthenia—Mitoxantrone—breast cancer	4.13e-05	0.000368	CcSEcCtD
Flutamide—Asthenia—Irinotecan—breast cancer	4.13e-05	0.000368	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	4.13e-05	0.000367	CcSEcCtD
Flutamide—Jaundice—Epirubicin—breast cancer	4.11e-05	0.000366	CcSEcCtD
Flutamide—Decreased appetite—Paclitaxel—breast cancer	4.08e-05	0.000364	CcSEcCtD
Flutamide—Hypertension—Capecitabine—breast cancer	4.08e-05	0.000363	CcSEcCtD
Flutamide—Fatigue—Paclitaxel—breast cancer	4.05e-05	0.000361	CcSEcCtD
Flutamide—Hepatitis—Methotrexate—breast cancer	4.04e-05	0.00036	CcSEcCtD
Flutamide—Asthenia—Gemcitabine—breast cancer	4.03e-05	0.000359	CcSEcCtD
Flutamide—Constipation—Paclitaxel—breast cancer	4.02e-05	0.000358	CcSEcCtD
Flutamide—Haematuria—Epirubicin—breast cancer	4.02e-05	0.000358	CcSEcCtD
Flutamide—Confusional state—Docetaxel—breast cancer	4.02e-05	0.000358	CcSEcCtD
Flutamide—Anxiety—Capecitabine—breast cancer	4.01e-05	0.000357	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	3.99e-05	0.000356	CcSEcCtD
Flutamide—Photosensitivity reaction—Doxorubicin—breast cancer	3.99e-05	0.000355	CcSEcCtD
Flutamide—Oedema—Docetaxel—breast cancer	3.98e-05	0.000355	CcSEcCtD
Flutamide—Discomfort—Capecitabine—breast cancer	3.97e-05	0.000354	CcSEcCtD
Flutamide—Pruritus—Gemcitabine—breast cancer	3.97e-05	0.000354	CcSEcCtD
Flutamide—Nausea—Thiotepa—breast cancer	3.96e-05	0.000353	CcSEcCtD
Flutamide—Hyperglycaemia—Doxorubicin—breast cancer	3.94e-05	0.000351	CcSEcCtD
Flutamide—Diarrhoea—Irinotecan—breast cancer	3.94e-05	0.000351	CcSEcCtD
Flutamide—Diarrhoea—Mitoxantrone—breast cancer	3.94e-05	0.000351	CcSEcCtD
Flutamide—Pruritus—Fluorouracil—breast cancer	3.9e-05	0.000348	CcSEcCtD
Flutamide—Thrombocytopenia—Docetaxel—breast cancer	3.9e-05	0.000347	CcSEcCtD
Flutamide—Drowsiness—Doxorubicin—breast cancer	3.9e-05	0.000347	CcSEcCtD
Flutamide—Confusional state—Capecitabine—breast cancer	3.89e-05	0.000346	CcSEcCtD
Flutamide—Feeling abnormal—Paclitaxel—breast cancer	3.87e-05	0.000345	CcSEcCtD
Flutamide—Skin disorder—Docetaxel—breast cancer	3.87e-05	0.000344	CcSEcCtD
Flutamide—Oedema—Capecitabine—breast cancer	3.86e-05	0.000343	CcSEcCtD
Flutamide—Diarrhoea—Gemcitabine—breast cancer	3.84e-05	0.000342	CcSEcCtD
Flutamide—Dizziness—Irinotecan—breast cancer	3.81e-05	0.000339	CcSEcCtD
Flutamide—Jaundice—Doxorubicin—breast cancer	3.8e-05	0.000338	CcSEcCtD
Flutamide—Anorexia—Docetaxel—breast cancer	3.8e-05	0.000338	CcSEcCtD
Flutamide—Hepatitis—Epirubicin—breast cancer	3.78e-05	0.000337	CcSEcCtD
Flutamide—Diarrhoea—Fluorouracil—breast cancer	3.77e-05	0.000336	CcSEcCtD
Flutamide—Thrombocytopenia—Capecitabine—breast cancer	3.77e-05	0.000336	CcSEcCtD
Flutamide—Skin disorder—Capecitabine—breast cancer	3.74e-05	0.000333	CcSEcCtD
Flutamide—Oedema peripheral—Epirubicin—breast cancer	3.72e-05	0.000332	CcSEcCtD
Flutamide—Haematuria—Doxorubicin—breast cancer	3.72e-05	0.000331	CcSEcCtD
Flutamide—Anorexia—Capecitabine—breast cancer	3.68e-05	0.000327	CcSEcCtD
Flutamide—Vomiting—Mitoxantrone—breast cancer	3.66e-05	0.000326	CcSEcCtD
Flutamide—Vomiting—Irinotecan—breast cancer	3.66e-05	0.000326	CcSEcCtD
Flutamide—Dizziness—Fluorouracil—breast cancer	3.65e-05	0.000325	CcSEcCtD
Flutamide—Rash—Mitoxantrone—breast cancer	3.63e-05	0.000323	CcSEcCtD
Flutamide—Rash—Irinotecan—breast cancer	3.63e-05	0.000323	CcSEcCtD
Flutamide—Dermatitis—Irinotecan—breast cancer	3.63e-05	0.000323	CcSEcCtD
Flutamide—Dermatitis—Mitoxantrone—breast cancer	3.63e-05	0.000323	CcSEcCtD
Flutamide—Headache—Irinotecan—breast cancer	3.61e-05	0.000321	CcSEcCtD
Flutamide—Headache—Mitoxantrone—breast cancer	3.61e-05	0.000321	CcSEcCtD
Flutamide—Insomnia—Docetaxel—breast cancer	3.6e-05	0.000321	CcSEcCtD
Flutamide—Vomiting—Gemcitabine—breast cancer	3.57e-05	0.000318	CcSEcCtD
Flutamide—Somnolence—Docetaxel—breast cancer	3.54e-05	0.000315	CcSEcCtD
Flutamide—Rash—Gemcitabine—breast cancer	3.54e-05	0.000315	CcSEcCtD
Flutamide—Dermatitis—Gemcitabine—breast cancer	3.53e-05	0.000315	CcSEcCtD
Flutamide—Erythema—Methotrexate—breast cancer	3.52e-05	0.000313	CcSEcCtD
Flutamide—Headache—Gemcitabine—breast cancer	3.52e-05	0.000313	CcSEcCtD
Flutamide—Vomiting—Fluorouracil—breast cancer	3.51e-05	0.000312	CcSEcCtD
Flutamide—Hepatitis—Doxorubicin—breast cancer	3.5e-05	0.000312	CcSEcCtD
Flutamide—Insomnia—Capecitabine—breast cancer	3.49e-05	0.000311	CcSEcCtD
Flutamide—Rash—Fluorouracil—breast cancer	3.48e-05	0.00031	CcSEcCtD
Flutamide—Dermatitis—Fluorouracil—breast cancer	3.48e-05	0.000309	CcSEcCtD
Flutamide—Decreased appetite—Docetaxel—breast cancer	3.46e-05	0.000308	CcSEcCtD
Flutamide—Headache—Fluorouracil—breast cancer	3.46e-05	0.000308	CcSEcCtD
Flutamide—Oedema peripheral—Doxorubicin—breast cancer	3.45e-05	0.000307	CcSEcCtD
Flutamide—Fatigue—Docetaxel—breast cancer	3.43e-05	0.000306	CcSEcCtD
Flutamide—Nausea—Irinotecan—breast cancer	3.42e-05	0.000305	CcSEcCtD
Flutamide—Nausea—Mitoxantrone—breast cancer	3.42e-05	0.000305	CcSEcCtD
Flutamide—Constipation—Docetaxel—breast cancer	3.41e-05	0.000303	CcSEcCtD
Flutamide—Asthenia—Paclitaxel—breast cancer	3.37e-05	0.0003	CcSEcCtD
Flutamide—Decreased appetite—Capecitabine—breast cancer	3.35e-05	0.000298	CcSEcCtD
Flutamide—Nausea—Gemcitabine—breast cancer	3.33e-05	0.000297	CcSEcCtD
Flutamide—Fatigue—Capecitabine—breast cancer	3.32e-05	0.000296	CcSEcCtD
Flutamide—Pruritus—Paclitaxel—breast cancer	3.32e-05	0.000296	CcSEcCtD
Flutamide—Constipation—Capecitabine—breast cancer	3.3e-05	0.000294	CcSEcCtD
Flutamide—Erythema—Epirubicin—breast cancer	3.29e-05	0.000293	CcSEcCtD
Flutamide—Feeling abnormal—Docetaxel—breast cancer	3.28e-05	0.000292	CcSEcCtD
Flutamide—Nausea—Fluorouracil—breast cancer	3.28e-05	0.000292	CcSEcCtD
Flutamide—Ill-defined disorder—Methotrexate—breast cancer	3.26e-05	0.000291	CcSEcCtD
Flutamide—Anaemia—Methotrexate—breast cancer	3.25e-05	0.000289	CcSEcCtD
Flutamide—Tension—Epirubicin—breast cancer	3.23e-05	0.000288	CcSEcCtD
Flutamide—Diarrhoea—Paclitaxel—breast cancer	3.21e-05	0.000286	CcSEcCtD
Flutamide—Nervousness—Epirubicin—breast cancer	3.2e-05	0.000285	CcSEcCtD
Flutamide—Feeling abnormal—Capecitabine—breast cancer	3.18e-05	0.000283	CcSEcCtD
Flutamide—Malaise—Methotrexate—breast cancer	3.17e-05	0.000282	CcSEcCtD
Flutamide—Leukopenia—Methotrexate—breast cancer	3.15e-05	0.00028	CcSEcCtD
Flutamide—Dizziness—Paclitaxel—breast cancer	3.11e-05	0.000277	CcSEcCtD
Flutamide—Ill-defined disorder—Epirubicin—breast cancer	3.05e-05	0.000272	CcSEcCtD
Flutamide—Erythema—Doxorubicin—breast cancer	3.05e-05	0.000271	CcSEcCtD
Flutamide—Anaemia—Epirubicin—breast cancer	3.04e-05	0.000271	CcSEcCtD
Flutamide—Tension—Doxorubicin—breast cancer	2.99e-05	0.000266	CcSEcCtD
Flutamide—Vomiting—Paclitaxel—breast cancer	2.99e-05	0.000266	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	2.97e-05	0.000265	CcSEcCtD
Flutamide—Malaise—Epirubicin—breast cancer	2.97e-05	0.000264	CcSEcCtD
Flutamide—Rash—Paclitaxel—breast cancer	2.96e-05	0.000264	CcSEcCtD
Flutamide—Dermatitis—Paclitaxel—breast cancer	2.96e-05	0.000264	CcSEcCtD
Flutamide—Discomfort—Methotrexate—breast cancer	2.96e-05	0.000263	CcSEcCtD
Flutamide—Nervousness—Doxorubicin—breast cancer	2.96e-05	0.000263	CcSEcCtD
Flutamide—Leukopenia—Epirubicin—breast cancer	2.95e-05	0.000262	CcSEcCtD
Flutamide—Headache—Paclitaxel—breast cancer	2.94e-05	0.000262	CcSEcCtD
Flutamide—Confusional state—Methotrexate—breast cancer	2.89e-05	0.000258	CcSEcCtD
Flutamide—Asthenia—Docetaxel—breast cancer	2.86e-05	0.000254	CcSEcCtD
Flutamide—Hypertension—Epirubicin—breast cancer	2.84e-05	0.000253	CcSEcCtD
Flutamide—Ill-defined disorder—Doxorubicin—breast cancer	2.83e-05	0.000252	CcSEcCtD
Flutamide—Pruritus—Docetaxel—breast cancer	2.82e-05	0.000251	CcSEcCtD
Flutamide—Anaemia—Doxorubicin—breast cancer	2.81e-05	0.000251	CcSEcCtD
Flutamide—Thrombocytopenia—Methotrexate—breast cancer	2.81e-05	0.00025	CcSEcCtD
Flutamide—Anxiety—Epirubicin—breast cancer	2.79e-05	0.000249	CcSEcCtD
Flutamide—Nausea—Paclitaxel—breast cancer	2.79e-05	0.000249	CcSEcCtD
Flutamide—Skin disorder—Methotrexate—breast cancer	2.79e-05	0.000248	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	2.78e-05	0.000248	CcSEcCtD
Flutamide—Discomfort—Epirubicin—breast cancer	2.77e-05	0.000247	CcSEcCtD
Flutamide—Asthenia—Capecitabine—breast cancer	2.77e-05	0.000246	CcSEcCtD
Flutamide—Malaise—Doxorubicin—breast cancer	2.75e-05	0.000245	CcSEcCtD
Flutamide—Anorexia—Methotrexate—breast cancer	2.74e-05	0.000244	CcSEcCtD
Flutamide—Pruritus—Capecitabine—breast cancer	2.73e-05	0.000243	CcSEcCtD
Flutamide—Leukopenia—Doxorubicin—breast cancer	2.73e-05	0.000243	CcSEcCtD
Flutamide—Diarrhoea—Docetaxel—breast cancer	2.72e-05	0.000243	CcSEcCtD
Flutamide—Confusional state—Epirubicin—breast cancer	2.71e-05	0.000241	CcSEcCtD
Flutamide—Oedema—Epirubicin—breast cancer	2.69e-05	0.000239	CcSEcCtD
Flutamide—Diarrhoea—Capecitabine—breast cancer	2.64e-05	0.000235	CcSEcCtD
Flutamide—Dizziness—Docetaxel—breast cancer	2.63e-05	0.000234	CcSEcCtD
Flutamide—Thrombocytopenia—Epirubicin—breast cancer	2.63e-05	0.000234	CcSEcCtD
Flutamide—Hypertension—Doxorubicin—breast cancer	2.63e-05	0.000234	CcSEcCtD
Flutamide—Skin disorder—Epirubicin—breast cancer	2.61e-05	0.000232	CcSEcCtD
Flutamide—Insomnia—Methotrexate—breast cancer	2.6e-05	0.000231	CcSEcCtD
Flutamide—Anxiety—Doxorubicin—breast cancer	2.58e-05	0.00023	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	2.57e-05	0.000229	CcSEcCtD
Flutamide—Discomfort—Doxorubicin—breast cancer	2.56e-05	0.000228	CcSEcCtD
Flutamide—Anorexia—Epirubicin—breast cancer	2.56e-05	0.000228	CcSEcCtD
Flutamide—Somnolence—Methotrexate—breast cancer	2.55e-05	0.000227	CcSEcCtD
Flutamide—Dizziness—Capecitabine—breast cancer	2.55e-05	0.000227	CcSEcCtD
Flutamide—Vomiting—Docetaxel—breast cancer	2.53e-05	0.000225	CcSEcCtD
Flutamide—Rash—Docetaxel—breast cancer	2.51e-05	0.000224	CcSEcCtD
Flutamide—Dermatitis—Docetaxel—breast cancer	2.51e-05	0.000223	CcSEcCtD
Flutamide—Confusional state—Doxorubicin—breast cancer	2.51e-05	0.000223	CcSEcCtD
Flutamide—Decreased appetite—Methotrexate—breast cancer	2.49e-05	0.000222	CcSEcCtD
Flutamide—Headache—Docetaxel—breast cancer	2.49e-05	0.000222	CcSEcCtD
Flutamide—Oedema—Doxorubicin—breast cancer	2.49e-05	0.000221	CcSEcCtD
Flutamide—Fatigue—Methotrexate—breast cancer	2.47e-05	0.00022	CcSEcCtD
Flutamide—Vomiting—Capecitabine—breast cancer	2.45e-05	0.000218	CcSEcCtD
Flutamide—Thrombocytopenia—Doxorubicin—breast cancer	2.43e-05	0.000217	CcSEcCtD
Flutamide—Rash—Capecitabine—breast cancer	2.43e-05	0.000216	CcSEcCtD
Flutamide—Insomnia—Epirubicin—breast cancer	2.43e-05	0.000216	CcSEcCtD
Flutamide—Dermatitis—Capecitabine—breast cancer	2.43e-05	0.000216	CcSEcCtD
Flutamide—Headache—Capecitabine—breast cancer	2.42e-05	0.000215	CcSEcCtD
Flutamide—Skin disorder—Doxorubicin—breast cancer	2.41e-05	0.000215	CcSEcCtD
Flutamide—Somnolence—Epirubicin—breast cancer	2.39e-05	0.000213	CcSEcCtD
Flutamide—Anorexia—Doxorubicin—breast cancer	2.37e-05	0.000211	CcSEcCtD
Flutamide—Nausea—Docetaxel—breast cancer	2.37e-05	0.000211	CcSEcCtD
Flutamide—Feeling abnormal—Methotrexate—breast cancer	2.37e-05	0.000211	CcSEcCtD
Flutamide—Decreased appetite—Epirubicin—breast cancer	2.33e-05	0.000208	CcSEcCtD
Flutamide—Fatigue—Epirubicin—breast cancer	2.32e-05	0.000206	CcSEcCtD
Flutamide—Constipation—Epirubicin—breast cancer	2.3e-05	0.000205	CcSEcCtD
Flutamide—Nausea—Capecitabine—breast cancer	2.29e-05	0.000204	CcSEcCtD
Flutamide—Insomnia—Doxorubicin—breast cancer	2.25e-05	0.0002	CcSEcCtD
Flutamide—Feeling abnormal—Epirubicin—breast cancer	2.21e-05	0.000197	CcSEcCtD
Flutamide—Somnolence—Doxorubicin—breast cancer	2.21e-05	0.000197	CcSEcCtD
Flutamide—Decreased appetite—Doxorubicin—breast cancer	2.16e-05	0.000192	CcSEcCtD
Flutamide—Fatigue—Doxorubicin—breast cancer	2.14e-05	0.000191	CcSEcCtD
Flutamide—Constipation—Doxorubicin—breast cancer	2.13e-05	0.000189	CcSEcCtD
Flutamide—Asthenia—Methotrexate—breast cancer	2.06e-05	0.000183	CcSEcCtD
Flutamide—Feeling abnormal—Doxorubicin—breast cancer	2.05e-05	0.000182	CcSEcCtD
Flutamide—Pruritus—Methotrexate—breast cancer	2.03e-05	0.000181	CcSEcCtD
Flutamide—Diarrhoea—Methotrexate—breast cancer	1.96e-05	0.000175	CcSEcCtD
Flutamide—Asthenia—Epirubicin—breast cancer	1.93e-05	0.000172	CcSEcCtD
Flutamide—Pruritus—Epirubicin—breast cancer	1.9e-05	0.000169	CcSEcCtD
Flutamide—Dizziness—Methotrexate—breast cancer	1.9e-05	0.000169	CcSEcCtD
Flutamide—Diarrhoea—Epirubicin—breast cancer	1.84e-05	0.000164	CcSEcCtD
Flutamide—Vomiting—Methotrexate—breast cancer	1.82e-05	0.000163	CcSEcCtD
Flutamide—Rash—Methotrexate—breast cancer	1.81e-05	0.000161	CcSEcCtD
Flutamide—Dermatitis—Methotrexate—breast cancer	1.81e-05	0.000161	CcSEcCtD
Flutamide—Headache—Methotrexate—breast cancer	1.8e-05	0.00016	CcSEcCtD
Flutamide—Asthenia—Doxorubicin—breast cancer	1.78e-05	0.000159	CcSEcCtD
Flutamide—Dizziness—Epirubicin—breast cancer	1.78e-05	0.000158	CcSEcCtD
Flutamide—Pruritus—Doxorubicin—breast cancer	1.76e-05	0.000157	CcSEcCtD
Flutamide—Vomiting—Epirubicin—breast cancer	1.71e-05	0.000152	CcSEcCtD
Flutamide—Nausea—Methotrexate—breast cancer	1.7e-05	0.000152	CcSEcCtD
Flutamide—Diarrhoea—Doxorubicin—breast cancer	1.7e-05	0.000151	CcSEcCtD
Flutamide—Rash—Epirubicin—breast cancer	1.69e-05	0.000151	CcSEcCtD
Flutamide—Dermatitis—Epirubicin—breast cancer	1.69e-05	0.000151	CcSEcCtD
Flutamide—Headache—Epirubicin—breast cancer	1.68e-05	0.00015	CcSEcCtD
Flutamide—Dizziness—Doxorubicin—breast cancer	1.64e-05	0.000146	CcSEcCtD
Flutamide—Nausea—Epirubicin—breast cancer	1.6e-05	0.000142	CcSEcCtD
Flutamide—Vomiting—Doxorubicin—breast cancer	1.58e-05	0.000141	CcSEcCtD
Flutamide—Rash—Doxorubicin—breast cancer	1.57e-05	0.00014	CcSEcCtD
Flutamide—Dermatitis—Doxorubicin—breast cancer	1.57e-05	0.000139	CcSEcCtD
Flutamide—Headache—Doxorubicin—breast cancer	1.56e-05	0.000139	CcSEcCtD
Flutamide—Nausea—Doxorubicin—breast cancer	1.48e-05	0.000131	CcSEcCtD
Flutamide—CYP3A5—Metabolism—HSP90AA1—breast cancer	2.9e-06	3.55e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—NAT2—breast cancer	2.88e-06	3.53e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—GSTT1—breast cancer	2.86e-06	3.52e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—ACHE—breast cancer	2.86e-06	3.52e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	2.85e-06	3.5e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—CYP3A4—breast cancer	2.84e-06	3.48e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	2.82e-06	3.47e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.82e-06	3.46e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—NCOA1—breast cancer	2.82e-06	3.46e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—UMPS—breast cancer	2.81e-06	3.45e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PHGDH—breast cancer	2.81e-06	3.45e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—ADSL—breast cancer	2.81e-06	3.45e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—NME1—breast cancer	2.81e-06	3.45e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—FHL2—breast cancer	2.81e-06	3.45e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—CYP1B1—breast cancer	2.79e-06	3.42e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—STK11—breast cancer	2.78e-06	3.41e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—CYP19A1—breast cancer	2.78e-06	3.41e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—BRIP1—breast cancer	2.76e-06	3.38e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—HPSE—breast cancer	2.76e-06	3.38e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—LDHB—breast cancer	2.76e-06	3.38e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—HSP90AA1—breast cancer	2.74e-06	3.36e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CYP17A1—breast cancer	2.71e-06	3.33e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PIK3CG—breast cancer	2.69e-06	3.3e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PTGS1—breast cancer	2.68e-06	3.3e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—ENO1—breast cancer	2.68e-06	3.3e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	2.67e-06	3.28e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—NCOA1—breast cancer	2.66e-06	3.27e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—breast cancer	2.64e-06	3.24e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CYP2D6—breast cancer	2.63e-06	3.23e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—STK11—breast cancer	2.62e-06	3.22e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—CYP19A1—breast cancer	2.62e-06	3.22e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GSTA3—breast cancer	2.61e-06	3.21e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—HMMR—breast cancer	2.61e-06	3.21e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—ABCC1—breast cancer	2.61e-06	3.21e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—breast cancer	2.6e-06	3.2e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—NCOA2—breast cancer	2.58e-06	3.17e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—COMT—breast cancer	2.58e-06	3.17e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—GSTP1—breast cancer	2.57e-06	3.15e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—HMOX1—breast cancer	2.53e-06	3.11e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PPARGC1B—breast cancer	2.53e-06	3.11e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—ITPR1—breast cancer	2.53e-06	3.1e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—MED12—breast cancer	2.52e-06	3.1e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—DPYD—breast cancer	2.52e-06	3.1e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—FASN—breast cancer	2.51e-06	3.08e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—BCHE—breast cancer	2.5e-06	3.06e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—ALDOA—breast cancer	2.48e-06	3.05e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—SLC5A5—breast cancer	2.46e-06	3.03e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.46e-06	3.02e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—COMT—breast cancer	2.44e-06	2.99e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—ABCB1—breast cancer	2.43e-06	2.99e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—GSTP1—breast cancer	2.43e-06	2.98e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—NCOA3—breast cancer	2.41e-06	2.96e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—SLC2A2—breast cancer	2.4e-06	2.94e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—HMOX1—breast cancer	2.39e-06	2.94e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GSTA4—breast cancer	2.39e-06	2.93e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CA9—breast cancer	2.39e-06	2.93e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—TYMS—breast cancer	2.39e-06	2.93e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—ITPR1—breast cancer	2.39e-06	2.93e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—SLC2A1—breast cancer	2.38e-06	2.92e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—NQO1—breast cancer	2.38e-06	2.92e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	2.37e-06	2.91e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PIK3CD—breast cancer	2.36e-06	2.9e-05	CbGpPWpGaD
Flutamide—AR—Gene Expression—MAPK3—breast cancer	2.36e-06	2.9e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PLA2G4A—breast cancer	2.36e-06	2.9e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—NCOR1—breast cancer	2.36e-06	2.9e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—GSTM1—breast cancer	2.36e-06	2.9e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—MTR—breast cancer	2.35e-06	2.88e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—ABCG2—breast cancer	2.35e-06	2.88e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CPT1A—breast cancer	2.35e-06	2.88e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—ALB—breast cancer	2.33e-06	2.86e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	2.33e-06	2.86e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GSTA2—breast cancer	2.33e-06	2.86e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GPX2—breast cancer	2.33e-06	2.86e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CYP3A4—breast cancer	2.32e-06	2.85e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	2.31e-06	2.84e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—HPGDS—breast cancer	2.3e-06	2.83e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GPX4—breast cancer	2.3e-06	2.82e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—SULT1A1—breast cancer	2.3e-06	2.82e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—ABCB1—breast cancer	2.3e-06	2.82e-05	CbGpPWpGaD
Flutamide—AR—Gene Expression—MYC—breast cancer	2.3e-06	2.82e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—HBA1—breast cancer	2.29e-06	2.81e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CYP1B1—breast cancer	2.28e-06	2.8e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—GPX1—breast cancer	2.26e-06	2.78e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—TYMS—breast cancer	2.26e-06	2.77e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—IDH1—breast cancer	2.25e-06	2.76e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GSTA1—breast cancer	2.25e-06	2.76e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—HSP90AA1—breast cancer	2.24e-06	2.75e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—CYP1A1—breast cancer	2.24e-06	2.75e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—GSTT1—breast cancer	2.23e-06	2.74e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—ACHE—breast cancer	2.23e-06	2.74e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—NOS3—breast cancer	2.23e-06	2.74e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—GSTM1—breast cancer	2.23e-06	2.74e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PLA2G4A—breast cancer	2.23e-06	2.74e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—NCOR1—breast cancer	2.23e-06	2.74e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—NAT2—breast cancer	2.22e-06	2.73e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—ERCC2—breast cancer	2.22e-06	2.72e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—NCOA1—breast cancer	2.18e-06	2.67e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—STK11—breast cancer	2.15e-06	2.63e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CYP19A1—breast cancer	2.15e-06	2.63e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—GPX1—breast cancer	2.14e-06	2.62e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CYP17A1—breast cancer	2.11e-06	2.59e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—ERCC2—breast cancer	2.1e-06	2.57e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PTGS1—breast cancer	2.09e-06	2.57e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—ENO1—breast cancer	2.09e-06	2.57e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—MTHFR—breast cancer	2.09e-06	2.56e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	2.08e-06	2.56e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PIK3CB—breast cancer	2.06e-06	2.53e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—breast cancer	2.06e-06	2.53e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CYP2D6—breast cancer	2.05e-06	2.52e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PTGS2—breast cancer	2.04e-06	2.51e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.01e-06	2.47e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—NCOA2—breast cancer	2.01e-06	2.47e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—COMT—breast cancer	2e-06	2.45e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—GSTP1—breast cancer	1.99e-06	2.44e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—MTHFR—breast cancer	1.97e-06	2.42e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—HMOX1—breast cancer	1.96e-06	2.4e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—ITPR1—breast cancer	1.95e-06	2.4e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—FASN—breast cancer	1.95e-06	2.4e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—MED12—breast cancer	1.95e-06	2.39e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—DPYD—breast cancer	1.95e-06	2.39e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—BCHE—breast cancer	1.94e-06	2.39e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—CAV1—breast cancer	1.92e-06	2.36e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—SLC5A5—breast cancer	1.92e-06	2.36e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—ALDOA—breast cancer	1.92e-06	2.35e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—ABCB1—breast cancer	1.88e-06	2.31e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—NCOA3—breast cancer	1.86e-06	2.29e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—NQO1—breast cancer	1.85e-06	2.28e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—SLC2A1—breast cancer	1.85e-06	2.28e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—SLC2A2—breast cancer	1.85e-06	2.27e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—TYMS—breast cancer	1.85e-06	2.27e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PLA2G4A—breast cancer	1.82e-06	2.24e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—NCOR1—breast cancer	1.82e-06	2.24e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—GSTM1—breast cancer	1.82e-06	2.24e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—CAV1—breast cancer	1.82e-06	2.23e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	1.82e-06	2.23e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CPT1A—breast cancer	1.81e-06	2.22e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—MTR—breast cancer	1.81e-06	2.22e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—ABCG2—breast cancer	1.81e-06	2.22e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CYP3A4—breast cancer	1.81e-06	2.22e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	1.8e-06	2.21e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PTEN—breast cancer	1.78e-06	2.19e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CYP1B1—breast cancer	1.78e-06	2.18e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—HPGDS—breast cancer	1.78e-06	2.18e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—HBA1—breast cancer	1.76e-06	2.17e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PIK3CG—breast cancer	1.75e-06	2.15e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—GPX1—breast cancer	1.75e-06	2.15e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—HSP90AA1—breast cancer	1.74e-06	2.14e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.74e-06	2.13e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CYP1A1—breast cancer	1.73e-06	2.12e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GSTT1—breast cancer	1.72e-06	2.12e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—ACHE—breast cancer	1.72e-06	2.12e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—ERCC2—breast cancer	1.72e-06	2.11e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—NCOA1—breast cancer	1.7e-06	2.08e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CYP19A1—breast cancer	1.67e-06	2.05e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—STK11—breast cancer	1.67e-06	2.05e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PIK3CG—breast cancer	1.66e-06	2.03e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CYP17A1—breast cancer	1.63e-06	2e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PTGS1—breast cancer	1.61e-06	1.98e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—ENO1—breast cancer	1.61e-06	1.98e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—MTHFR—breast cancer	1.61e-06	1.98e-05	CbGpPWpGaD
Flutamide—AR—Gene Expression—AKT1—breast cancer	1.59e-06	1.96e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CYP2D6—breast cancer	1.58e-06	1.94e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.57e-06	1.93e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—COMT—breast cancer	1.55e-06	1.91e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—NCOA2—breast cancer	1.55e-06	1.91e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—GSTP1—breast cancer	1.55e-06	1.9e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PIK3CD—breast cancer	1.54e-06	1.89e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—HMOX1—breast cancer	1.53e-06	1.87e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—ITPR1—breast cancer	1.52e-06	1.87e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—ALB—breast cancer	1.52e-06	1.87e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—FASN—breast cancer	1.51e-06	1.85e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—BCHE—breast cancer	1.5e-06	1.84e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CAV1—breast cancer	1.49e-06	1.83e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—SLC5A5—breast cancer	1.48e-06	1.82e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—ABCB1—breast cancer	1.46e-06	1.8e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PIK3CD—breast cancer	1.46e-06	1.79e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—NOS3—breast cancer	1.45e-06	1.79e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—TYMS—breast cancer	1.44e-06	1.77e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—ALB—breast cancer	1.44e-06	1.76e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—SLC2A1—breast cancer	1.43e-06	1.76e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—NQO1—breast cancer	1.43e-06	1.76e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PLA2G4A—breast cancer	1.42e-06	1.75e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—NCOR1—breast cancer	1.42e-06	1.75e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—GSTM1—breast cancer	1.42e-06	1.75e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.42e-06	1.74e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—NOS3—breast cancer	1.37e-06	1.69e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CYP1B1—breast cancer	1.37e-06	1.69e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—GPX1—breast cancer	1.36e-06	1.67e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PIK3CG—breast cancer	1.35e-06	1.66e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CYP1A1—breast cancer	1.35e-06	1.65e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—HSP90AA1—breast cancer	1.35e-06	1.65e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PIK3CB—breast cancer	1.34e-06	1.65e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—ERCC2—breast cancer	1.34e-06	1.64e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PTGS2—breast cancer	1.33e-06	1.63e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—NCOA1—breast cancer	1.31e-06	1.61e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CYP19A1—breast cancer	1.29e-06	1.58e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—STK11—breast cancer	1.29e-06	1.58e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PIK3CB—breast cancer	1.27e-06	1.56e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PTGS2—breast cancer	1.26e-06	1.54e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—MTHFR—breast cancer	1.26e-06	1.54e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PIK3CA—breast cancer	1.26e-06	1.54e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—COMT—breast cancer	1.2e-06	1.47e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GSTP1—breast cancer	1.19e-06	1.47e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PIK3CD—breast cancer	1.19e-06	1.46e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—HMOX1—breast cancer	1.18e-06	1.45e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—ALB—breast cancer	1.18e-06	1.44e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—ITPR1—breast cancer	1.17e-06	1.44e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PTEN—breast cancer	1.16e-06	1.42e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CAV1—breast cancer	1.16e-06	1.42e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—ABCB1—breast cancer	1.13e-06	1.39e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—NOS3—breast cancer	1.12e-06	1.38e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—TYMS—breast cancer	1.11e-06	1.36e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.11e-06	1.36e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—NCOR1—breast cancer	1.1e-06	1.35e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.1e-06	1.35e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GSTM1—breast cancer	1.1e-06	1.35e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PTEN—breast cancer	1.1e-06	1.35e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PIK3CG—breast cancer	1.06e-06	1.3e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GPX1—breast cancer	1.05e-06	1.29e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CYP1A1—breast cancer	1.04e-06	1.28e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PIK3CB—breast cancer	1.04e-06	1.27e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—ERCC2—breast cancer	1.03e-06	1.27e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PTGS2—breast cancer	1.03e-06	1.26e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—AKT1—breast cancer	1.03e-06	1.26e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—MTHFR—breast cancer	9.7e-07	1.19e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PIK3CD—breast cancer	9.28e-07	1.14e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—ALB—breast cancer	9.16e-07	1.12e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PTEN—breast cancer	8.97e-07	1.1e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CAV1—breast cancer	8.94e-07	1.1e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—NOS3—breast cancer	8.76e-07	1.08e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PIK3CA—breast cancer	8.19e-07	1.01e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PIK3CG—breast cancer	8.15e-07	1e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PIK3CB—breast cancer	8.09e-07	9.93e-06	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PTGS2—breast cancer	8.02e-07	9.84e-06	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PIK3CA—breast cancer	7.73e-07	9.5e-06	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PIK3CD—breast cancer	7.16e-07	8.79e-06	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—ALB—breast cancer	7.07e-07	8.68e-06	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PTEN—breast cancer	6.99e-07	8.58e-06	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—NOS3—breast cancer	6.76e-07	8.3e-06	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—AKT1—breast cancer	6.69e-07	8.21e-06	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PIK3CA—breast cancer	6.33e-07	7.77e-06	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—AKT1—breast cancer	6.32e-07	7.76e-06	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PIK3CB—breast cancer	6.24e-07	7.67e-06	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PTGS2—breast cancer	6.19e-07	7.6e-06	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PTEN—breast cancer	5.39e-07	6.62e-06	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—AKT1—breast cancer	5.17e-07	6.35e-06	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PIK3CA—breast cancer	4.93e-07	6.05e-06	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—AKT1—breast cancer	4.03e-07	4.95e-06	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PIK3CA—breast cancer	3.81e-07	4.67e-06	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—AKT1—breast cancer	3.11e-07	3.82e-06	CbGpPWpGaD
